US cancer drug shortage forces doctors to ration life-saving treatments
A severe shortage of cancer therapies is forcing thousands of patients to miss life-saving treatments, several leading healthcare organisations have warned.
There are 14 oncology medicines listed “in shortage” by US regulators, including the generic chemotherapy drugs cisplatin and carboplatin, which are first-line treatments for many common types of cancer.
Drug shortages are not new. But experts warn a growing reliance on offshore manufacturing, increasing demand, market consolidation and pricing pressure has made the US particularly vulnerable to them.
This story originally appeared on: Financial Times - Author:Jamie Smyth
